TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million April 12, 1985
TCL Archive Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention January 21, 2011
